Favrille, Inc. Overview
biopharmaceutical company focused on the development and commercialization of patient-specific immunotherapies for the treatment of cancer and other diseases of the immune system. We own a proprietary technology that enables us to efficiently develop and manufacture active immunotherapy products designed to stimulate a patient's own immune system to mount a specific and sustained response to...More»
biopharmaceutical company focused on the development and commercialization of patient-specific immunotherapies for the treatment of cancer and other diseases of the immune system. We own a proprietary technology that enables us to efficiently develop and manufacture active immunotherapy products designed to stimulate a patient's own immune system to mount a specific and sustained response to disease.«Less
Key People
Management
Funding
No funding information added yet. Add funding information.
Products
| Name: | Anti-CD20 Antibodies |
| Product URL: | http://www.favrille.com/tech/development-programs.htm |
Competitors
No competitors have been recorded yet. Add a competitor.
Related Companies
User Opinions
Bulls vs. Bears (0)
| Bullish Opinions (0) | ||||
|---|---|---|---|---|
| Be the first to tell us why they are destined to succeed | ||||
| Bearish Opinions (0) | ||||
|---|---|---|---|---|
| Be the first to tell us why they are destined to stumble. | ||||
Discussions (0)
Start a New Discussion
Opinion Poll
View All Opinions »Web Metrics
View All Web Metrics »News & Blogs
View All News »- Latest
- Most Popular
- Submit a Story »
Favrille and MyMedicalRecords.com, Inc. Plan to Complete Merger in January 2009
Jan 2, 2009 - 0 comments
Favrille, Inc. on Twitter
Twitter Search »Discussions
View All Discussions »There are no discussions right now.
Recent Contributors
There are no recent contributors to this company.
Related Jobs
loading...

Profile
Opinions
